Developing a critical vaccine manufacturing facility in Quebec with Moderna

Project overview

Building resilience against future pandemics 

Moderna is a pharmaceutical company with a mission to deliver the greatest possible impact to people through mRNA, including one of the earliest and most effective COVID-19 vaccines. Moderna’s first mRNA facility in Canada will build local resilience for future pandemic responses and the facility was expected to be operational in 2025, with a capacity of 100m doses per year.

Project story

Driving an integrated project schedule 

In March 2023 we were appointed to provide project management, schedule management, risk, and cost and commercial management capabilities for construction on the facility, with our contract later including the completion of the CQV (commissioning, qualification and verification).  

Key to our involvement was the creation of a project execution plan, including an integrated project schedule, effective implementation of project controls, and the streamlining of decision-making and approval processes. Our ability to build strong relationships between construction management and principal designer, creating a ‘one-team’ mindset, was a key factor in delivering the project.  

Following the successful completion of our work on the Laval project, we have since been appointed by Moderna to several additional global projects, including the Genomics Lab Expansion at Moderna’s headquarters in Massachusetts, as well as to provide project management support on real estate projects globally. 

A developing partnership 

Underscoring Moderna’s commitment to sustainability and achieving decarbonisation goals, the design of the facility aims to significantly reduce fossil-fuel usage. Moderna has targeted achieving net-zero emissions in scopes 1 and 2 by 2030. 

As well as prioritising sustainability, Moderna’s work aims to strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks.